Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TARS
$73.58
-2.49%
TARS
· Tarsus Pharmaceuticals, Inc.
$73.58
-1.88 (-2.49%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$3.32B
Shares
43.88M
Volume · Oct 2
285.68K
Avg daily vol (3M)
943.54K
All webcasts
Earnings call · FY2021 Q3
Tarsus Pharmaceuticals, Inc. (TARS) Q3 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$1.24M
Diluted EPS
-$0.76
Net income
-$15.70M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 10, 2021 · complete as-filed document